Methods for treating drug resistant cancer

US8299081B2 · kind B2 · utility

Assignee

• Novartis AG · CH

Inventors

• Glenn Michelson · Emeryville, US
• Vivien Chan · Emeryville, US
• Carla Heise · Benicia, US
• Marion Wiesmann · Emeryville, US
• Timothy D. Dawes · Scotts Valley, US

Key dates

• Filing date: May 10, 2006
• Grant date: Oct 30, 2012
• Expiry date: Jul 23, 2027

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P35/02
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A method for treating drug-resistant cancer, includes: administering to a patient in need thereof, a compound of formula I, a tautomer of the compound, a salt of the compound, a salt of the tautomer, a mixture thereof, or a pharmaceutical composition comprising the compound, the tautomer, the salt of the compound, the salt of the tautomer, or the mixture, wherein the patient is a cancer patient with drug-resistant cancer, wherein the compound of Formula I is as defined in the application.